Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Magnesium Sulphate for Emergence Agitation in Sinus Surgery
NCT07677917Phase 1Enrolling by invitation
- Sponsor
- Ain Shams University
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Emergence agitation (EA) comparing Group D (Dexmedetomedine) with Group M (Magnesium Sulphate) (2 arms). Primary endpoint: Visual Analogue Scale score at 30 months. Started Jan 2026; status: enrolling by invitation.
02
Drugs
dexmedetomidinemagnesium sulfate
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT07677917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677917.